Proline rich-oligopeptides: Diverse mechanisms for antihypertensive action

Peptides

Volumn 48, Issue , 2013, Pages 124-133

  Morais, Katia L P ^a,b   Ianzer, Danielle ^a,c   Miranda, José Rodolfo R ^a,b   Melo, Robson L ^a   Guerreiro, Juliano R ^d   Santos, Robson A S ^e   Ulrich, Henning ^f   Lameu, Claudiana ^f  

^a INSTITUTO BUTANTAN   (Brazil)

^b FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^c FEDERAL UNIVERSITY OF OURO PRETO   (Brazil)

^d Centro de Biotecnologia Agrícola CEBTEC   (Brazil)

^e FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^f UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Argininosuccinate synthetase; Heart rate; Mean arterial pressure; Muscarinic acetylcholine receptor; Nitric oxide; Proline rich oligopeptides

Indexed keywords

ANTIHYPERTENSIVE AGENT; ARGININOSUCCINATE SYNTHASE; BRADYKININ; DIPEPTIDYL CARBOXYPEPTIDASE; MUSCARINIC M3 RECEPTOR; OLIGOPEPTIDE; PROLINE RICH PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTERIAL PRESSURE; ARTICLE; BLOOD PRESSURE REGULATION; BOTHROPS JARARACA; CARDIOVASCULAR EFFECT; DRUG EFFECT; ENZYME ACTIVITY; HUMAN; HUMAN CELL; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

BOTHROPS JARARACA;

([CA(2+)](I)); 4-DAMP; 4-[(DIPHENYLACETYL)OXY]-1,1-DIMETHYL-PIPERIDINIUM IODIDE; ACE; ANGIOTENSIN I-CONVERTING ENZYME; ARGININOSUCCINATE SYNTHETASE; ASS; BJ; BK; BOTHROPS JARARACA; BRADYKININ; C-TYPE NATRIURETIC PEPTIDE; CENTRAL NERVOUS SYSTEM; CNP; CNS; HEART RATE; HR; INTRACELLULAR CALCIUM CONCENTRATION; MACHRS; MAP; MDLA; MEAN ARTERIAL PRESSURE; MUSCARINIC ACETYLCHOLINE RECEPTOR; MUSCARINIC RECEPTORS; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NO; NOS; PAP; PRO; PROLINE-RICH OLIGOPEPTIDE; PROLINE-RICH OLIGOPEPTIDES; PULSATILE ARTERIAL PRESSURE; SHR; SPONTANEOUSLY HYPERTENSIVE RAT; Α-METHYL-DL-ASPARTIC ACID;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; ANTIHYPERTENSIVE AGENTS; BOTHROPS; BRADYKININ; HUMANS; HYPERTENSION; OLIGOPEPTIDES; PEPTIDYL-DIPEPTIDASE A; PROLINE-RICH PROTEIN DOMAINS; SNAKE VENOMS;

EID: 84883138907     PISSN: 01969781     EISSN: 18735169     Source Type: Journal    
DOI: 10.1016/j.peptides.2013.07.016     Document Type: Article

References (39)

1. Bunag RD, Walaszek EJ, Mueting N. Sex differences in reflex tachycardia induced by hypotensive drugs in unanesthetized rats. Am J Physiol 1975;229:652-6.
2. Camargo AC, Ianzer D, Guerreiro JR, Serrano SM. Bradykinin-potentiating peptides: beyond captopril. Toxicon 2012;59:516-23.
3. Cotton J, Hayashi MA, Cuniasse P, Vazeux G, Ianzer D, De Camargo AC, et al. Selective inhibition of the C-domain of angiotensin I converting enzyme by bradykinin potentiating peptides. Biochemistry 2002;41:6065-71. (Pubitemid 34498912)
4. de Oliveira EF, Guerreiro JR, Silva CA, Benedetti GF, Lebrun I, Ulrich H, et al. Enhancement of the citrulline-nitric oxide cycle in astroglioma cells by the proline-rich peptide-10c from Bothrops jararaca venom. Brain Res 2010;1363:11-9.
5. Feelisch M, Rassaf T, Mnaimneh S, Singh N, Bryan NS, Jourd'Heuil D, et al. Concomitant S-, N-, and heme-nitros(yl)ation in biological tissues and fluids: implications for the fate of NO in vivo. Faseb J 2002;16:1775-85. (Pubitemid 35340358)
6. Ferreira SH, Bartelt DC, Greene LJ. Isolation of bradykinin-potentiating peptides from Bothrops jararaca venom. Biochemistry 1970;9:2583-93.
7. Georgopapadakou NH, Liu FY, Ryono DE, Neubeck R, Ondetti MA. Chemical modifications of the active site of Streptomyces R61 DD-carboxypeptidase. Eur J Biochem 1981;115:53-7. (Pubitemid 11107858)
8. Gomes CL, Konno K, Conceicao IM, Ianzer D, Yamanouye N, Prezoto BC, et al. Identification of novel bradykinin-potentiating peptides (BPPs) in the venom gland of a rattlesnake allowed the evaluation of the structure-function relationship of BPPs. Biochem Pharmacol 2007;74:1350-60. (Pubitemid 47445446)
9. Gordon FJ, Sved AF. Neurotransmitters in central cardiovascular regulation: glutamate and GABA. Clin Exp Pharmacol Physiol 2002;29:522-4. (Pubitemid 34535379)
10. Guerreiro JR, Lameu C, Oliveira EF, Klitzke CF, Melo RL, Linares E, et al. Argininosuccinate synthetase is a functional target for a snake venom antihypertensive peptide: role in arginine and nitric oxide production. J Biol Chem 2009;284:20022-33.
11. Hao G, Xie L, Gross SS. Argininosuccinate synthetase is reversibly inactivated by S-nitrosylation in vitro and in vivo. J Biol Chem 2004;279:36192-200. (Pubitemid 39128954)
12. Hayashi MA, Camargo AC. The Bradykinin-potentiating peptides from venom gland and brain of Bothrops jararaca contain highly site specific inhibitors of the somatic angiotensin-converting enzyme. Toxicon 2005;45:1163-70. (Pubitemid 40732588)
13. Hayashi MA, Murbach AF, Ianzer D, Portaro FC, Prezoto BC, Fernandes BL, et al. The C-type natriuretic peptide precursor of snake brain contains highly specific inhibitors of the angiotensin-converting enzyme. J Neurochem 2003;85:969-77. (Pubitemid 36578628)
14. Ianzer D, Konno K, Marques-Porto R, Vieira Portaro FC, Stocklin R, Martins de Camargo AC, et al. Identification of five new bradykinin potentiating peptides (BPPs) from Bothrops jararaca crude venom by using electrospray ionization tandem mass spectrometry after a two-step liquid chromatography. Peptides 2004;25:1085-92. (Pubitemid 38881647)
15. Ianzer D, Konno K, Xavier CH, Stocklin R, Santos RA, de Camargo AC, et al. Hemorphin and hemorphin-like peptides isolated from dog pancreas and sheep brain are able to potentiate bradykinin activity in vivo. Peptides 2006;27:2957-66. (Pubitemid 44596239)
16. Ianzer D, Santos RA, Etelvino GM, Xavier CH, de Almeida Santos J, Mendes EP, et al. Do the cardiovascular effects of angiotensin-converting enzyme (ACE) I involve ACE-independent mechanisms? new insights from proline-rich peptides of Bothrops jararaca. J Pharmacol Exp Ther 2007;322:795-805. (Pubitemid 47105778)
17. Ianzer D, Xavier CH, Fraga FC, Lautner RQ, Guerreiro JR, Machado LT, et al. BPP- 5a produces a potent and long-lasting NO-dependent antihypertensive effect. Ther Adv Cardiovasc Dis 2011;5:281-95.
18. Ianzer DA, Silveira KD, Teixeira MM, Simoes e Silva AC, Camargo ACM. BPPs from Bothrops jararaca venom change renal function of SHR. FASEB J 2011;25:643.9.
19. Kakar P, Lip GY. Towards improving the clinical assessment and management of human hypertension: An overview from this Journal. J Hum Hypertens 2006;20:913-6. (Pubitemid 44782823)
20. Kanagy NL. Alpha(2)-adrenergic receptor signalling in hypertension. Clin Sci (Lond) 2005;109:431-7.
21. Keim Jr GR, Kirpan J, Peterson AE, Murphy BF, Hassert Jr GL, Poutsiaka JW. Inhibition of angiotensin I-initiated hemodynamic changes in anesthetized dogs by a synthetic nonapeptide. Proc Soc Exp Biol Med 1972;140:149-52.
22. Lameu C, Hayashi MA, Guerreiro JR, Oliveira EF, Lebrun I, Pontieri V, et al. The central nervous system as target for antihypertensive actions of a proline-rich peptide from Bothrops jararaca venom. Cytometry A 2010;77:220-30.
23. Lameu C, Pontieri V, Guerreiro JR, Oliveira EF, da Silva CA, Giglio JM, et al. Brain nitric oxide production by a proline-rich decapeptide from Bothrops jararaca venom improves baroreflex sensitivity of spontaneously hypertensive rats. Hypertens Res 2010;33:1283-8.
24. Leenders AG, Sheng ZH. Modulation of neurotransmitter release by the second messenger-activated protein kinases: implications for presynaptic plasticity. Pharmacol Ther 2005;105:69-84. (Pubitemid 40038871)
25. Maier LS. Ca(2+)/calmodulin-dependent protein kinase II (CaMKII) in the heart. Adv Exp Med Biol 2012;740:685-702.
26. Majumder P, Trujillo CA, Lopes CG, Resende RR, Gomes KN, Yuahasi KK, et al. New insights into purinergic receptor signaling in neuronal differentiation, neuroprotection, and brain disorders. Purinergic Signal 2007;3:317-31.
27. Martins-Pinge MC, Mueller PJ, Foley CM, Heesch CM, Hasser EM. Regulation of arterial pressure by the paraventricular nucleus in conscious rats: interactions among glutamate, GABA, and nitric oxide. Front Physiol 2012;3:490.
28. Morais KL, Hayashi MA, Bruni FM, Lopes-Ferreira M, Camargo AC, Ulrich H, et al. Bj-PRO-5a, a natural angiotensin-converting enzyme inhibitor, promotes vasodilatation mediated by both bradykinin B(2)and M1 muscarinic acetylcholine receptors. Biochem Pharmacol 2011;81:736-42.
29. Mueller S, Gothe R, Siems WD, Vietinghoff G, Paegelow I, Reissmann S. Potentiation of bradykinin actions by analogues of the bradykinin potentiating nonapeptide BPP9alpha. Peptides 2005;26:1235-47. (Pubitemid 40798081)
30. Murayama N, Hayashi MA, Ohi H, Ferreira LA, Hermann VV, Saito H, et al. Cloning and sequence analysis of a Bothrops jararaca cDNA encoding a precursor of seven bradykinin-potentiating peptides and a C-type natriuretic peptide. Proc Natl Acad Sci U S A 1997;94:1189-93. (Pubitemid 27087826)
31. Negraes PD, Lameu C, Hayashi MA, Melo RL, Camargo AC, Ulrich H. The snake venom peptide Bj-PRO-7a is a M1 muscarinic acetylcholine receptor agonist. Cytometry A 2011;79:77-83.
32. Ondetti MA, Williams NJ, Sabo EF, Pluscec J, Weaver ER, Kocy O. Angiotensinconverting enzyme inhibitors from the venom of Bothrops jararaca. Isolation, elucidation of structure, and synthesis. Biochemistry 1971;10:4033-9.
33. Silva CA, Portaro FC, Fernandes BL, Ianzer DA, Guerreiro JR, Gomes CL, et al. Tissue distribution in mice of BPP 10c, a potent proline-rich anti-hypertensive peptide of Bothrops jararaca. Toxicon 2008;51:515-23.
34. Solomonson LP, Flam BR, Pendleton LC, Goodwin BL, Eichler DC. The caveolar nitric oxide synthase/arginine regeneration system for NO production in endothelial cells. J Exp Biol 2003;206:2083-7. (Pubitemid 36761811)
35. Somsen RJ, Jennings JR, Van der Molen MW. The cardiac cycle time effect revisited: temporal dynamics of the central-vagal modulation of heart rate in human reaction time tasks. Psychophysiology 2004;41:941-53. (Pubitemid 40051482)
36. Svendsen UG. The importance of thymus for hypertension and hypertensive vascular disease in rats and mice. Acta Pathol Microbiol Scand Suppl 1978: 1-15.
37. Tashima AK, Zelanis A, Kitano ES, Ianzer D, Melo RL, Rioli V, et al. Peptidomics of three Bothrops snake venoms: insights into the molecular diversification of proteomes and peptidomes. Mol Cell Proteomics 2012;11:1245-62.
38. Vollmer RR, Boccagno JA, Harris DN, Murthy VS. Hypotension induced by inhibition of angiotensin-converting enzyme in pentobarbital-anesthetized dogs. Eur J Pharmacol 1978;51:39-45. (Pubitemid 9197602)
39. Wess J. Muscarinic acetylcholine receptor knockout mice: novel phenotypes and clinical implications. Annu Rev Pharmacool Toxicol 2004;44: 423-50. (Pubitemid 38263848)